Tempus AI (NASDAQ:TEM) Shares Down 0.5% – Should You Sell?

Tempus AI, Inc. (NASDAQ:TEM) shares fell 0.5% on Friday . The stock traded as low as $34.82 and last traded at $37.30. 1,160,993 shares were traded during mid-day trading, a decline of 65% from the average session volume of 3,336,246 shares. The stock had previously closed at $37.49.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on TEM shares. Bank of America increased their target price on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a research report on Friday, December 13th. Piper Sandler reiterated a “neutral” rating and issued a $70.00 target price (up previously from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Wolfe Research assumed coverage on Tempus AI in a report on Friday, December 13th. They issued an “outperform” rating and a $60.00 target price on the stock. Loop Capital raised their price target on Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a report on Tuesday, October 15th. Finally, Guggenheim initiated coverage on Tempus AI in a research note on Monday, December 9th. They issued a “buy” rating and a $74.00 price objective on the stock. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat.com, Tempus AI presently has an average rating of “Moderate Buy” and a consensus target price of $56.00.

Tempus AI Stock Performance

The company has a fifty day simple moving average of $48.45 and a two-hundred day simple moving average of $46.89. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.

Insider Transactions at Tempus AI

In other Tempus AI news, Director David R. Epstein sold 620 shares of the company’s stock in a transaction that occurred on Wednesday, December 11th. The stock was sold at an average price of $41.81, for a total transaction of $25,922.20. Following the completion of the transaction, the director now owns 27,894 shares of the company’s stock, valued at $1,166,248.14. This represents a 2.17 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Andrew Polovin sold 51,504 shares of Tempus AI stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $42.39, for a total transaction of $2,183,254.56. Following the completion of the sale, the executive vice president now owns 246,085 shares in the company, valued at $10,431,543.15. This trade represents a 17.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 865,041 shares of company stock valued at $35,917,673 over the last quarter.

Institutional Investors Weigh In On Tempus AI

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. First Horizon Advisors Inc. acquired a new stake in shares of Tempus AI in the 3rd quarter valued at approximately $30,000. Vestor Capital LLC acquired a new stake in Tempus AI in the third quarter valued at $153,000. Stifel Financial Corp acquired a new stake in Tempus AI in the third quarter valued at $218,000. Sandia Investment Management LP bought a new position in shares of Tempus AI in the 2nd quarter valued at about $136,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd acquired a new position in shares of Tempus AI during the 3rd quarter worth about $258,000. 24.22% of the stock is owned by institutional investors.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.